47 related articles for article (PubMed ID: 3087271)
1. Potential animal models for senile dementia of Alzheimer's type, with emphasis on AF64A-induced cholinotoxicity.
Fisher A; Hanin I
Annu Rev Pharmacol Toxicol; 1986; 26():161-81. PubMed ID: 3087271
[TBL] [Abstract][Full Text] [Related]
2. Glycosaminoglycan C3 protects against AF64A-induced cholinotoxicity in a dose-dependent and time-dependent manner.
Rose M; Dudas B; Cornelli U; Hanin I
Brain Res; 2004 Jul; 1015(1-2):96-102. PubMed ID: 15223371
[TBL] [Abstract][Full Text] [Related]
3. Regional differences in ethylcholine mustard aziridinium ion (AF64A)-induced deficits in presynaptic cholinergic markers for the rat central nervous system.
Vickroy TW; Watson M; Leventer SM; Roeske WR; Hanin I; Yamamura HI
J Pharmacol Exp Ther; 1985 Dec; 235(3):577-82. PubMed ID: 3841155
[TBL] [Abstract][Full Text] [Related]
4. Possible mechanisms involved in the presynaptic cholinotoxicity due to ethylcholine aziridinium (AF64A) in vivo.
Mantione CR; Fisher A; Hanin I
Life Sci; 1984 Jul; 35(1):33-41. PubMed ID: 6330483
[TBL] [Abstract][Full Text] [Related]
5. Arecoline via miniosmotic pump improves AF64A-impaired radial maze performance in rats: a possible model of Alzheimer's disease.
Bartolomeo AC; Morris H; Boast CA
Neurobiol Learn Mem; 1997 Nov; 68(3):333-42. PubMed ID: 9398593
[TBL] [Abstract][Full Text] [Related]
6. AF64A-induced brain damage and its relation to dementia.
Hörtnagl H
J Neural Transm Suppl; 1994; 44():245-57. PubMed ID: 7897396
[TBL] [Abstract][Full Text] [Related]
7. The AF64A model of cholinergic hypofunction: an update.
Hanin I
Life Sci; 1996; 58(22):1955-64. PubMed ID: 8637424
[TBL] [Abstract][Full Text] [Related]
8. AF64A-induced changes in N-myc expression in the LA-N-2 human neuroblastoma cell line are modulated by choline and hemicholinium-3.
Santiago LR; Erickson LC; Hanin I
Neurochem Res; 1998 May; 23(5):743-50. PubMed ID: 9566614
[TBL] [Abstract][Full Text] [Related]
9. Neurochemistry of aging. 1. Toxins for an animal model of Alzheimer's disease.
Mistry JS; Abraham DJ; Hanin I
J Med Chem; 1986 Mar; 29(3):376-80. PubMed ID: 3950917
[TBL] [Abstract][Full Text] [Related]
10. Intracerebral injections of AF64A: an animal model of Alzheimer's disease?
Jarrard LE; Levy A; Meyerhoff JL; Kant GJ
Ann N Y Acad Sci; 1985; 444():520-2. PubMed ID: 3860115
[No Abstract] [Full Text] [Related]
11. Vitamin E prevents the place learning deficit and the cholinergic hypofunction induced by AF64A.
Wörtwein G; Stackman RW; Walsh TJ
Exp Neurol; 1994 Jan; 125(1):15-21. PubMed ID: 8307121
[TBL] [Abstract][Full Text] [Related]
12. Long-term central cholinergic hypofunction induced in mice by ethylcholine aziridinium ion (AF64A) in vivo.
Fisher A; Mantione CR; Abraham DJ; Hanin I
J Pharmacol Exp Ther; 1982 Jul; 222(1):140-5. PubMed ID: 6896342
[TBL] [Abstract][Full Text] [Related]
13. Selective inhibition of peripheral cholinergic transmission in the cat produced by AF64A.
Mantione CR; deGroat WC; Fisher A; Hanin I
J Pharmacol Exp Ther; 1983 Jun; 225(3):616-22. PubMed ID: 6306213
[TBL] [Abstract][Full Text] [Related]
14. Molecular analysis of non-specific supersensitivity induced by AF64A in rat iris smooth muscle.
Ikeno N; Furuta M; Yamahara NS; Ohya S; Imaizumi Y; Watanabe M
J Smooth Muscle Res; 2000 Apr; 36(2):47-56. PubMed ID: 10983592
[TBL] [Abstract][Full Text] [Related]
15. Dimebon improves learning in animals with experimental Alzheimer's disease.
Lermontova NN; Lukoyanov NV; Serkova TP; Lukoyanova EA; Bachurin SO
Bull Exp Biol Med; 2000 Jun; 129(6):544-6. PubMed ID: 11022244
[TBL] [Abstract][Full Text] [Related]
16. Neuroplasticity, the aging brain, and Alzheimer's disease.
Walsh TJ; Opello KD
Neurotoxicology; 1992; 13(1):101-10. PubMed ID: 1508410
[TBL] [Abstract][Full Text] [Related]
17. AF64A lesions of mouse striatum result in ipsilateral rotations to D2 dopamine agonists but contralateral rotations to muscarinic cholinergic agonists.
Zhou LW; Zhang SP; Connell TA; Weiss B
J Pharmacol Exp Ther; 1993 Feb; 264(2):824-30. PubMed ID: 8094754
[TBL] [Abstract][Full Text] [Related]
18. Deficits in cholinergic neurotransmission markers induced by ethylcholine mustard aziridinium (AF64A) in the rat hippocampus: sensitivity to treatment with the monoamine oxidase-B inhibitor L-deprenyl.
Ricci A; Mancini M; Strocchi P; Bongrani S; Bronzetti E
Drugs Exp Clin Res; 1992; 18(5):163-71. PubMed ID: 1490432
[TBL] [Abstract][Full Text] [Related]
19. Regional and laminar distribution of nodules in rat cerebral cortex after injection of the cholinergic neurotoxin: AF64A.
Fuentes C; König N; Roch G
Z Mikrosk Anat Forsch; 1987; 101(6):1035-9. PubMed ID: 3450091
[No Abstract] [Full Text] [Related]
20. Differential effects of intracerebroventricular AF64A injection, nucleus basalis of Meynert lesion, and scopolamine on place navigation and open-field behavior of rats.
Ogishima M; Hiraga Y; Washizuka M; Kobayashi N; Nakata N; Ikeda Y
Yakubutsu Seishin Kodo; 1992 Apr; 12(2):85-92. PubMed ID: 1441764
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
